Hydrogen Gas May Reduce Inflammation in Blood Machines in Lab Tests
Molecular Hydrogen and Extracorporeal Gas Exchange: A Match Made in Heaven? An In Vitro Pilot Study
Research hubs: Oxidative Stress · Cardiovascular System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Foivos Leonidas Mouzakis, Flutura Hima, Ali Kashefi, Johannes Greven, Lothar Rink, Emiel P. C. van der Vorst, Joachim Jankowski, Khosrow Mottaghy, Jan Spillner
- Journal
- Biomedicines
- Year
- 2024
- PMID
- 39200347
- Study Type
- Cell Culture
- Participants
- 7
- Delivery
- Medium (Dissolved)
- Dose
- H2 gas mixture injected into ECMO circuit
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 4 (OpenAlex, as of November 2026)
- Country
- Germany
TL;DR
Adding molecular hydrogen (H2) to a blood circulation system used in medical treatments may reduce inflammation and oxidative stress caused by the treatment itself.
Key Finding
Hydrogen gas reduced inflammatory and oxidative stress markers in blood samples exposed to bacterial toxins during simulated extracorporeal circulation, compared to untreated samples.
Summary
Researchers tested whether hydrogen gas could reduce inflammation and oxidative stress (cellular damage from unstable molecules) in blood samples circulated through machines similar to those used in dialysis and heart-lung bypass procedures. They exposed blood samples to a bacterial toxin known to trigger inflammation, and added hydrogen gas to some samples. After 6 hours, samples treated with hydrogen showed lower levels of inflammatory markers compared to untreated samples, suggesting hydrogen may help protect blood during these medical procedures.
Practical Takeaway
This is an early-stage laboratory study using blood samples in test tubes, not human patients, so results cannot yet be applied to real medical practice. The findings suggest hydrogen may warrant further investigation for protecting patients during dialysis and bypass procedures, but much more research—including human trials—is needed to determine safe and effective dosing before any clinical use.
Abstract (excerpt)
Extracorporeal circulation (ECC) is frequently implemented in a vast array of modalities such as hemodialysis, cardiopulmonary bypass, extracorporeal membrane oxygenation (ECMO), and others. Patients receiving any such therapy are frequently encumbered with chronic inflammation, which is inherently…